SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Frostman who wrote (4882)1/21/1998 11:09:00 PM
From: blankmind  Read Replies (1) of 23519
 
-- Great VVUS post from the Wall Street Journal. I especially like the part where the Paine analyst says their production woes are behind them.

-- After the trash piece in Barron's, I thought there'd be something about the hanging weight study from Italy.

-- This publicity is good. New investors and straddlers are going to look at the balance sheet. See $93 or so mill in cash. $1+ earnings per share. New ad campaigns. New capacity. Etc.... And it's going to add to demand. Add the 10+ mill short position. The 1.6 mill shares to be bought back. And we could have a squuze in the making. Shorts are toast.

Out.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News